---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041006"
form_type: "8-K"
ticker: null
cik: "0001603207"
company_name: "Notable Labs, Ltd."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:34:56.720432+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Notable Labs files Chapter 7 bankruptcy; all directors resign, officers terminated

## Summary
- Filed voluntary Chapter 7 petitions on Oct 13, 2024, in Delaware Bankruptcy Court for itself and four subsidiaries.
- A Chapter 7 trustee will be appointed to liquidate assets and pay claims under the Bankruptcy Code.
- All directors (Tuomo Pätsi, Dubin, Feinberg, Galen, Graney, Rice) resigned effective Oct 13 upon filing.
- CFO Scott A. McPherson, CSO Joseph Wagner, and interim CEO/restructuring officer Kaile A. Zagger terminated Oct 8.
- Company has no board members remaining; operations effectively cease.

## SEC filing metadata
- accession: 0001493152-24-041006
- form_type: 8-K
- cik: 0001603207
- company_name: Notable Labs, Ltd.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041006
- JSON: https://secwatch.observer/filing/0001493152-24-041006.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041006.txt

## Key facts
- Distress & Bankruptcy
  Notable Labs, Ltd. entered chapter 7 in United States Bankruptcy Court for the District of Delaware (petition 2024-10-13).
  - Proceeding: chapter 7
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2024-10-13
  source text: After considering strategic alternatives, Notable Labs, Ltd. (the “ Company ” or “ Notable ”) and its subsidiaries filed a voluntary petition for relief (the “ Petitions ”) under the provisions of chapter 7 of title 11 of the United States Code, 11 U.S.C. §§ 101, et seq. (the “ Bankruptcy Code ”) in the United States Bankruptcy Court for the District of Delaware (the “ Bankruptcy Court ”) on October 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Peter Feinberg resigned as Director at Notable Labs, Ltd..
  - Action: resigned
  - Role: Director
  source text: Tuomo Pätsi, Thomas I. H. Dubin, Peter Feinberg, Michele Galen, Thomas Graney and Michael Rice tendered their resignations as members of the Company’s and its subsidiaries’ Boards of Directors, which resignations were effective on October 13, 2024 as of immediately following the filing of the Petitions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Thomas I. H. Dubin resigned as Director at Notable Labs, Ltd..
  - Action: resigned
  - Role: Director
  source text: Tuomo Pätsi, Thomas I. H. Dubin, Peter Feinberg, Michele Galen, Thomas Graney and Michael Rice tendered their resignations as members of the Company’s and its subsidiaries’ Boards of Directors, which resignations were effective on October 13, 2024 as of immediately following the filing of the Petitions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Tuomo Pätsi resigned as Director at Notable Labs, Ltd..
  - Action: resigned
  - Role: Director
  source text: Tuomo Pätsi, Thomas I. H. Dubin, Peter Feinberg, Michele Galen, Thomas Graney and Michael Rice tendered their resignations as members of the Company’s and its subsidiaries’ Boards of Directors, which resignations were effective on October 13, 2024 as of immediately following the filing of the Petitions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Michele Galen resigned as Director at Notable Labs, Ltd..
  - Action: resigned
  - Role: Director
  source text: Tuomo Pätsi, Thomas I. H. Dubin, Peter Feinberg, Michele Galen, Thomas Graney and Michael Rice tendered their resignations as members of the Company’s and its subsidiaries’ Boards of Directors, which resignations were effective on October 13, 2024 as of immediately following the filing of the Petitions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Kaile A. Zagger was terminated as Chief Restructuring Officer and Interim Chief Executive Officer at Notable Labs, Ltd..
  - Action: terminated
  - Role: Chief Restructuring Officer and Interim Chief Executive Officer
  source text: The Company also terminated Scott A. McPherson, the Company’s Chief Financial Officer, and Joseph Wagner, the Company’s Chief Scientific Officer, each effective October 8, 2024, and the Company’s Chief Restructuring Officer and Interim Chief Executive Officer, Kaile A. Zagger, was also terminated from such positions and became an advisor to the Company effective as of October 8, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Scott A. McPherson was terminated as Chief Financial Officer at Notable Labs, Ltd..
  - Action: terminated
  - Role: Chief Financial Officer
  source text: The Company also terminated Scott A. McPherson, the Company’s Chief Financial Officer, and Joseph Wagner, the Company’s Chief Scientific Officer, each effective October 8, 2024, and the Company’s Chief Restructuring Officer and Interim Chief Executive Officer, Kaile A. Zagger, was also terminated from such positions and became an advisor to the Company effective as of October 8, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Michael Rice resigned as Director at Notable Labs, Ltd..
  - Action: resigned
  - Role: Director
  source text: Tuomo Pätsi, Thomas I. H. Dubin, Peter Feinberg, Michele Galen, Thomas Graney and Michael Rice tendered their resignations as members of the Company’s and its subsidiaries’ Boards of Directors, which resignations were effective on October 13, 2024 as of immediately following the filing of the Petitions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Thomas Graney resigned as Director at Notable Labs, Ltd..
  - Action: resigned
  - Role: Director
  source text: Tuomo Pätsi, Thomas I. H. Dubin, Peter Feinberg, Michele Galen, Thomas Graney and Michael Rice tendered their resignations as members of the Company’s and its subsidiaries’ Boards of Directors, which resignations were effective on October 13, 2024 as of immediately following the filing of the Petitions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm
- Executive change
  Joseph Wagner was terminated as Chief Scientific Officer at Notable Labs, Ltd..
  - Action: terminated
  - Role: Chief Scientific Officer
  source text: The Company also terminated Scott A. McPherson, the Company’s Chief Financial Officer, and Joseph Wagner, the Company’s Chief Scientific Officer, each effective October 8, 2024, and the Company’s Chief Restructuring Officer and Interim Chief Executive Officer, Kaile A. Zagger, was also terminated from such positions and became an advisor to the Company effective as of October 8, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224041006/0001493152-24-041006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.